Ozgur Sirkeci

Dr. Ozgur Sirkeci

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
OSOzgur Sirkeci
Ozgur Sirkeci
ESEmel Erkuş Sirkeci
Emel Erkuş Sirkeci
TUTurgay Ulaş
Turgay Ulaş
Background: In this study, we aimed to evaluate whether waterpipe smoking can be associated with the transmission of Helicobacter pylori infection or not. Materials and Methods: Between March 2018 and April 2019, 445 patients aged over 18 years old who were admitted to outpatient clinics with dyspeptic complaints were recruited for the study. Patients are divided into two groups – Group 1 is H. pylori-positive patients and Group 2 is negative. Waterpipe smoking, smoking, age, gender, and educational status were compared among groups. Results: Two hundred and sixty-one women (58%) and 184 men (42%), totally 445 patients, tested for H. pylori infection. Seventy-nine of 261 (30%) women and 60 of 184 (32%) men had H. pylori positive. One hundred and sixty-two of 445 (36%) patients were smoking cigarette and 66 of 445 (14%) patients were using waterpipe tobacco. Waterpipe smoking individuals were found to be associated with the H. pylori positivity (P < 0.001); whereas, age, gender, educational level, and smoking were not found to be statistically significant (all P > 0.05). In binary logistic regression analysis, waterpipe tobacco smoking was found to be the only independent predictor of H. pylori infection (P < 0.001, odds ratio = 5.51, confidence interval: 3.158–9.617). Conclusion: Waterpipe smoking seems to be an important risk factor for H. pylori infection and may be one of the reasons of high prevalence of H. pylori infection.

1 June 2021 in Clinical and Experimental Health Sciences
Verified
Journal Article
Closed access
TYTuba Yerli̇kaya
Tuba Yerli̇kaya
BÇBilge Başakci Çalik
Bilge Başakci Çalik
UCUGUR CAVLAK
UGUR CAVLAK
OSOzgur Sirkeci
Ozgur Sirkeci
Objective: The aim of this study was to evaluate the upper extremity functions of individuals with type 2 diabetes mellitus and to compare them with those of healthy subjects. Methods: The study included 36 diabetic patients (mean age: 55.05 +/- 5.85 years; 21 female, 15 male) and 36 healthy control subjects (mean age: 53.52 +/- 7.74 years; 20 female, 16 male). Grip strength was evaluated using a hand dynamometer. Upper extremity endurance was evaluated using the Unsupported Upper Limb Exercise Test (UULEX), and upper extremity disability level with the Disabilities of the Arm Shoulder and Hand Test (DASH-T). Results: The diabetic patients obtained lower scores of upper extremity endurance (p<0.05) and the disability level of the diabetics was found to be higher than that of the healthy control group (p0.05). Conclusion: In individuals with type 2 diabetes mellitus, there is a significant decrease in upper extremity endurance and an increase in the level of upper extremity disability.

8 May 2023 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
OSOzgur Sirkeci
Ozgur Sirkeci
ESEmel Erkus Sirkeci
Emel Erkus Sirkeci
NSNeslihan Ergün Süzer
Neslihan Ergün Süzer
ATAli Cankut Tatlıparmak
Ali Cankut Tatlıparmak
YKYasemin Küçükçiloğlu
Yasemin Küçükçiloğlu
TUTurgay Ulaş
Turgay Ulaş

30 June 2017 in Journal of Family Medicine and Disease Prevention
Verified
Journal Article
Open access
OSOzgur Sirkeci
Ozgur Sirkeci
Diabetes mellitus (DM) is known to be associated with serious cardiovascular risk and the prevalence of DM amongst population is rapidly increasing. When important risk factors such as age, hypercholesterolemia, obesity and coronary artery disease are excluded, DM still continues to be an important risk factor for cardiovascular disease. Diastolic dysfunction is an early complication of type 2 diabetes and diabetic cardiomyopathy is known to be the first step of the process.

3 May 2019 in The European Research Journal
Verified
Journal Article
Open access
PDF file
OSOzgur Sirkeci
Ozgur Sirkeci
ESEmel Erkuş Sirkeci
Emel Erkuş Sirkeci
BTBelma Taşel
Belma Taşel
Rivaroxaban is a direct factor Xa inhibitor and has been safely used since 2008. It is used for the detection of atrial fibrillation and venous thromboembolism. Pancreatitis is one of the rare but dangerous side effects of rivaroxaban. The case of a 53-year-old female patient that developed in the third month of drug usage was evaluated, and it was confirmed after a full analysis was conducted that excluded all other factors, such as biliary calculus, alcohol usage, hypertriglyceridemia, biochemical parameters, ultrasonography and computed tomography that the patient’s condition was caused by the use of Rivaroxaban. The aim of this case presentation is to indicate that awareness should be increased regarding the risks of using the drug Rivaroxaban, as it could lead to drug-induced pancreatitis, even though this is rare.

1 August 2014
Verified
Closed access
MKMuammer Kara
Muammer Kara
ATAlpaslan Tanoğlu
Alpaslan Tanoğlu
AKAli Kutlu
Ali Kutlu
OSOzgur Sirkeci
Ozgur Sirkeci
MKMurat Kekilli
Murat Kekilli